Evaluating the Protective Effect of Ailanthus altissima (Mill.) Swingle in a Rat Model of Acetic Acid-Induced Ulcerative Colitis
-
Mohammad Mehdi Gravandi
,
Seyede Zahra Hosseini
,
Seyede Darya Alavi
,
Seyed Mohammad Reza Jafari
,
Mohsen Zhaleh
,
Mohammad Hossein Farzaei
Abstract
Inflammatory bowel disease (IBD) has two subtypes called ulcerative colitis (UC) and Crohn's disease (CD). They have the same tissue damage processes; however, differ in the initial procedures and immune regulatory aberrations. Tumor necrosis factor-alpha (TNF-α) appears to have an important function and a key pathogenic role in CD and UC. In this paper, we evaluated the protective impact of the extract of Ailanthus altissima (Mill.) Swingle (tree of heaven), Simaroubaceae, in acetic acid-induced UC. Ferric-reducing capacity of plant extract, total phenols, and total flavonoid contents were measured in A. altissima ethanolic extract. Thirty male rats were randomly divided into six groups including control, normal, mesalazine 300 mg/kg (positive control) and 3 treatment groups with doses of 50, 100, and 200 mg/kg for 7 days. Except for the normal group, all animals received 2 mL of 4% acetic acid infusion into the large intestine. Upon 48 h after the last gavage, the animals were euthanized. Acetic acid intracolonic administration resulted in a severe acute inflammation in the colonic tissue, which was improved by A. altissima extract at all examined doses in both microscopic and macroscopic aspects. In comparison to the control, TNF-α was considerably lower in the mesalazine and 200 mg/kg A. altissima extract groups. Conclusively, the valuable effects of the extract in the treatment of UC were confirmed by TNF-α levels, histological data, and macroscopic observations, especially at 200 mg/kg dosage. Future studies are recommended to further clarify the action mechanisms of this plant.
Colitis-Pathophysiology U. Inflammatory bowel disease part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003;8:247-283.
Goyal N, Rana A, Ahlawat A, Bijjem KRV, Kumar P. Animal models of inflammatory bowel disease: a review. Inflammopharmacology 2014;22:219-233.
Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ulcerative colitis: diagnosis and treatment. Am Fam Physician 2007;76:1323-1330.
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, et al. A comprehensive review and update on ulcerative colitis. Dis-a-Mon 2019;65:100851.
Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease. Gastrointest. Endosc. Clin N Am 1995;24:475-507.
Sarlos P, Kovesdi E, Magyari L, Banfai Z, Szabo A, et al. Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World J Gastrointest Pathophysiol 2014;5:304-321.
Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 2002;97:2577-2584.
Van Deventer S. Tumour necrosis factor and Crohn's disease. Gut 1997;40:443-448.
Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998;42:470-476.
Borruel N, Carol M, Casellas F, Antolin M, De Lara F, et al. Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51:659-664.
Bebb J, Scott B. How effective are the usual treatments for ulcerative colitis? Aliment Pharmacol Ther 2004;20:143-149.
Luís Â, Gil N, Amaral ME, Domingues F, Duarte APC. Ailanthus altissima (Miller) Swingle: A source of bioactive compounds with antioxidant activity. BioResources 2012;7:2105-2120.
Kowarik I, Säumel I. Biological flora of central Europe: Ailanthus altissima (Mill.) swingle. Perspect Plant Ecol Evol Syst 2007;8:207-237.
Sladonja B, Sušek M, Guillermic J. Review on invasive tree of heaven (Ailanthus altissima (Mill.) Swingle) conflicting values: assessment of its ecosystem services and potential biological threat. Environ Manage 2015;56:1009-1034.
Kim HM, Lee JS, Sezirahiga J, Kwon J, Jeong M, et al. A new canthinone-type alkaloid isolated from Ailanthus altissima Swingle. Molecules 2016;21:642.
Hu SY. Ailanthus Arnoldia 1979;39:29-50.
Fabia R, Willen R, Ar’Rajab A, Andersson R, Ahren B, et al. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992;24:211-225.
Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, et al. Effects of dexpanthenol on acetic acid‑induced colitis in rats. Exp Med 2016;12:2958-2964.
Dudonné S, Vitrac X, Coutière P, Woillez M, Mérillon JM. Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays. J Agric Food Chem 2009;57:1768-1774.
Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-76.
Al-Farsi M, Alasalvar C, Morris A, Baron M, Shahidi F. Comparison of antioxidant activity, anthocyanins, carotenoids, and phenolics of three native fresh and sun-dried date (Phoenix dactylifera L.) varieties grown in Oman. J Agric Food Chem 2005;53:7592-7599.
Chandra S, Khan S, Avula B, Lata H, Yang MH, et al. Assessment of total phenolic and flavonoid content, antioxidant properties, and yield of aeroponically and conventionally grown leafy vegetables and fruit crops: a comparative study. Evid Based Complementary Altern Med 2014;2014:253875.
Sekizuka E, Grisham MB, Li MA, Deitch EA, Granger DN. Inflammation-induced intestinal hyperemia in the rat: role of neutrophils. Gastroenterology 1988;95:1528-1534.
Abdolghaffari AH, Baghaei A, Moayer F, Esmaily H, Baeeri M, et al. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators. Hum Exp Toxicol 2010;29:287-295.
Burisch J, Jess T, Martinato M, Lakatos PL, ECCO-EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7:322-337.
Bing X. The pathogenesis and etiology of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2001;9:246-250.
Akazawa A, Sakaida I, Higaki S, Kubo Y, Uchida K, et al. Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J Gastroenterol 2002;37:345-353.
Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors Hum Mol Genet 2002;11:1281-1289.
Indaram AV, Visvalingam V, Locke M, Bank S. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease. Am J. Gastroenterol 2000;95:1221-1225.
Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, et al. Tumor necrosis factor-α in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem 2001;47:1297-1301.
Wang Q, Xu L. Experimental examination and active assessment of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2000;8:336-2007.
Guo J, Sheng Z, Tan S. Active index of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2001;9:1431-1434.
Bingham CO. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl 2002;65:3-9.
Tian L, Huang YX, Tian M, Gao W, Chang Q. Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol 2003;9:1028-1033.
MacDonald T, Monteleone G, Pender S. Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 2000;51:2-9.
Vishwakarma N, Ganeshpurkar A, Pandey V, Dubey N, Bansal D. Mesalazine–probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis. Drug Deliv 2015;22:94-99.
Li N, Lu R, Yu Y, Lu Y, Huang L, et al. Protective effect of Periplaneta americana extract in ulcerative colitis rats induced by dinitrochlorobenzene and acetic acid. Pharm Biol 2016;54:2560-2567.
Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, et al. Effects of dexpanthenol on acetic acid-induced colitis in rats. Exp Ther Med 2016;12:2958-2964.
De Feo V, Martino LD, Santoro A, Leone A, Pizza C, et al. Antiproliferative effects of tree‐of‐heaven (Ailanthus altissima Swingle). Phytother Res 2005;19:226-230.
Murakami N, Sugimoto M, Kawanishi M, Tamura S, Kim H-S, et al. New semisynthetic quassinoids with in vivo antimalarial activity. J Med Chem 2003;46:638-641.
Rahman A, Kim EL, Kang SC. Antibacterial and antioxidant properties of Ailanthus altissima Swingle leave extract to reduce foodborne pathogens and spoiling bacteria. J Food Saf 2009;29:499-510.
Lü J-H, He Y-Q. Fumigant toxicity of Ailanthus altissima Swingle, Atractylodes lancea (Thunb.) DC. and Elsholtzia stauntonii Benth extracts on three major stored-grain insects. Ind Crops Prod 2010;32:681-683.
Rahimi R, Ghiasi S, Azimi H, Fakhari S, Abdollahi M. A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs. Cytokine 2010;49:123-129.
Li X, Li Y, Ma S, Zhao Q, Wu J, et al. Traditional uses, phytochemistry, and pharmacology of Ailanthus altissima (Mill.) Swingle bark: A comprehensive review. J Ethnopharmacol 2021;275:114121.
Albouchi F, Hassen I, Casabianca H, Hosni K. Phytochemicals, antioxidant, antimicrobial and phytotoxic activities of Ailanthus altissima (Mill.) Swingle leaves. S. Afr J Bot 2013;87:164-174.
Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol 2002:117:101-139.
Kang T-H, Choi I-Y, Kim S-J, Moon P-D, Seo J-U, et al. Ailanthus altissima swingle has anti-anaphylactic effect and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation. In Vitro Cell Dev Biol Anim 2010;46:72-81.
Andrade-Oliveira V, Câmara NO, Moraes-Vieira PM. Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res 2015;2015:681612.
Fausel R, Afzali A. Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists. Ther Clin Risk Manag 2015;11:63-73.
Catanzaro R, Occhipinti S, Calabrese F, Anzalone MG, Milazzo M, et al. Irritable bowel syndrome: new findings in pathophysiological and therapeutic field. Minerva Gastroenterol Dietol 2014;60:151-163.
Pedersen J, Coskun M, Soendergaard C, Salem M, Nielsen OH. Inflammatory pathways of importance for management of inflammatory bowel disease. World J Gastroenterol 2014;20:64-77.
Cho S-K, Jeong M, Jang DS, Choi J-H. Anti-inflammatory Effects of Canthin-6-one Alkaloids from Ailanthus altissima. Planta Med 2018;50:527-535.
| Files | ||
| Issue | Vol 8, No 3, 2023 | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/tim.v8i3.13708 | |
| Keywords | ||
| Ailanthus altissima Acetic acid Colitis Inflammatory Bowel Disease (IBD) | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
